insights_auto
Why is TWST down 18.55%?
Dive Deeperchevron_right
TWST:NASDAQ
Twist Bioscience Corp
$166.97
arrow_downward
-18.55%(-38.03) 1D
$167.02
arrow_upward
+0.03% (+0.050)bedtimeAfter hours
Closed: Oct 6, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TWST...
Open
$209.55
High
$219.71
Low
$164.49
Mkt. cap
10.18B
Avg. vol.
2.11M
Volume
0.00
52-wk high
$219.71
52-wk low
$23.30
EPS
-$2.22
Beta
2.19
Shares outstanding
65.83M
No. of employees
979
Open
$209.55
High
$219.71
Low
$164.49
Mkt. cap
10.18B
Avg. vol.
2.11M
Volume
0.00
52-wk high
$219.71
52-wk low
$23.30
EPS
-$2.22
Beta
2.19
Shares outstanding
65.83M
No. of employees
979
News stories
From web sources and news partners
Investing.com
·
10 hours ago
Why is Twist Bioscience stock plunging today?
TipRanks
·
13 hours ago
Bearish Wall Street Call Knocks Twist Bioscience Lower
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp